BBSRC Portfolio Analyser

Investigator / Supervisor details

NameProfessor Andrew Baker
Current InstitutionUniversity of Edinburgh
Current DepartmentCentre for Cardiovascular Science
Institution websitehttp://www.ed.ac.uk
Previous InstitutionsUniversity of Glasgow

Current Awards

No current BBSRC awards

Completed Awards

ReferenceTitleAward RoleValue £Type
BB/C000048/1 Selective gene delivery to the vasculature using peptide-modified adenoviral vectors Principal Investigator 205,228 Research Grant
BB/E020844/1 Evaluating the impact of coagulation factors on gene delivery using pseudotyped adenoviruses: receptor usage bioavailability and immunogenicity Principal Investigator 188,997 Research Grant
BB/E02145X/2 Evaluating the impact of coagulation factors on gene delivery using pseudotyped adenoviruses: receptor usage bioavailability and immunogenicity Principal Investigator 24,621 Research Grant
BB/E02503X/1 A new strategy to achieve targeted adenoviral gene delivery in vivo: mechanistic and therapeutic insights Principal Investigator 290,723 Research Grant
BB/F005423/1 The role of endothelial tryptophan hydroxylase in pulmonary vascular remodelling: an integrated approach Co-investigator 434,285 Research Grant
BB/G016844/1 Interrogation of the adenovirus hexon: A new paradigm for virus biology and application to therapeutic gene delivery Principal Investigator 690,136 Research Grant
BB/H020675/1 Master of Research in Biomedical Sciences with a specialisation in Integrative Mammalian Biology (IMB) [Systems] Co-investigator 339,005 Training Grants
BB/I005927/1 Refinement and assessment of a novel adenovirus targeting platform for application to human gene therapy Principal Investigator 383,092 Research Grant
BB/I53297X/1 Improved adenoviral gene therapy vectors via combined genetic modification of the adenovirus capsid to ablate interaction with blood coagulation factor X and to provide new targeting moieties Principal Investigator 186,896 Research Grant
BB/L027933/1 Adenovirus and coagulation factor interactions and the impact on virus stability and utility for gene therapy Principal Investigator 468,403 Research Grant
BB/L027933/2 Adenovirus and coagulation factor interactions and the impact on virus stability and utility for gene therapy Principal Investigator 362,223 Research Grant
E17190 Targeted delivery of gene-based medicines to vascular endothelium Principal Investigator 139,333 Research Grant
GTH12582 Re-targeting adenoviruses to the vascular endothelium for safe and effective gene therapy of diverse pathologies Principal Investigator 331,314 Research Grant
terms and conditions of use (opens in new window)
export PDF file
back to list new search